-
The agency plans to reduce the incentive for doctors to use the most expensive drugs and link prices to patient outcomes, perhaps paying less when patients have to be admitted to a hospital.
-
Untested cancer drugs are often hyped by journalists, doctors and biotech firms, a survey finds. Dressing up unproved medications with shiny words can inspire false optimism among patients.